Evidence map›Paper›PMID 30824632›Full record

SynthesisJournal of neurology, neurosurgery, and psychiatry2019

Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials.

Uwe Reuter, Candace McClure, Eric Liebler, Patricia Pozo-Rosich

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Journal of neurology, neurosurgery, and psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07633067 (Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine), which is not on this map. Cited by 39 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07633067 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Efficacy of Middle Meningeal Artery Embolization for the Treatment of Migraine: A Multicenter, Prospective, Double-blind, Multigroup, Randomized Controlled Trial.

TypeinterventionalSponsorThe Affiliated Hospital Of Guizhou Medical UniversityRan2026 to 2028Enrolled150ConditionsMigraineArmsMiddle meningeal artery embolization, Conventional standard pharmacotherapy for migraine
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  7. Pooled it
  8. Trial
  9. Resonance massage tool effects in non-migraine headache management.Journal of oral & facial pain and headache · 2025
    Trial
  10. Trial
  11. Review
  12. Review
  13. Review
  14. Article
  15. Hallmarks of primary headache: part 3 - cluster headache.The journal of headache and pain · 2025
    Review
  16. The potential application of electrophysiological indicators in TMS treatment for MOH.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Review
  17. Review
  18. Article
  19. Article
  20. Non-Pharmacological Treatment for Chronic Migraine.Current pain and headache reports · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Uwe ReuterDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany uwe.reuter@charite.de.ORCID 0000-0002-8527-0725
Candace McClureNorth American Science Associates, Minneapolis, Minnesota, USA.
Eric LieblerelectroCore, Inc, Basking Ridge, New Jersey, USA.
Patricia Pozo-RosichHeadache and Craniofacial Pain Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-invasive neuromodulation therapies for migraine and cluster headache are a practical and safe alternative to pharmacologics. Comparisons of these therapies are difficult because of the heterogeneity in study designs. In this systematic review of clinical trials, the scientific rigour and clinical relevance of the available data were assessed to inform clinical decisions about non-invasive neuromodulation. PubMed, Cochrane Library and ClinicalTrials.gov databases and the WHO's International Clinical Trials Registry Platform were searched for relevant clinical studies of non-invasive neuromodulation devices for migraine and cluster headache (1 January 1990 to 31 January 2018), and 71 were identified. This analysis compared study designs using recommendations of the International Headache Society for pharmacological clinical trials, the only available guidelines for migraine and cluster headache. Non-invasive vagus nerve stimulation (nVNS), single-transcranial magnetic stimulation and external trigeminal nerve stimulation (all with regulatory clearance) were well studied compared with the other devices, for which studies frequently lacked proper blinding, sham controls and sufficient population sizes. nVNS studies demonstrated the most consistent adherence to available guidelines. Studies of all neuromodulation devices should strive to achieve the same high level of scientific rigour to allow for proper comparison across devices. Device-specific guidelines for migraine and cluster headache will be soon available, but adherence to current guidelines for pharmacological trials will remain a key consideration for investigators and clinicians.

Indexed as

Transcutaneous Electric Nerve StimulationCluster HeadacheElectric Stimulation TherapyHumansMigraine DisordersRandomized Controlled Trials as TopicTranscranial Magnetic StimulationTreatment OutcomeTrigeminal NerveVagus Nerve Stimulationevidence-based neurologyheadachemigrainerandomised trialssystematic reviews

Identifiers

PMID30824632
PMCPMC6585264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.